Attached files
| file | filename |
|---|---|
| EX-21.1 - EXHIBIT 21.1 - AERIE PHARMACEUTICALS INC | aeri12312015ex211.htm |
| EX-31.1 - EXHIBIT 31.1 - AERIE PHARMACEUTICALS INC | aeri12312015ex-311.htm |
| EX-32.2 - EXHIBIT 32.2 - AERIE PHARMACEUTICALS INC | aeri12312015ex-322.htm |
| EX-31.2 - EXHIBIT 31.2 - AERIE PHARMACEUTICALS INC | aeri12312015ex-312.htm |
| EX-32.1 - EXHIBIT 32.1 - AERIE PHARMACEUTICALS INC | aeri12312015ex-321.htm |
| 10-K - 10-K - AERIE PHARMACEUTICALS INC | aeri-1231201510xk.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-199821) and Form S-8 (No. 333-192030) of Aerie Pharmaceuticals, Inc. of our report dated March 2, 2016 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Florham Park, NJ
March 2, 2016